CLINICAL_TRIALS
trial_result
· 2014-05-20
Clinical Trial Update: An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis [Phase 3]
Summary
This Phase 3 trial update reports efficacy and safety results of ustekinumab in adults with plaque psoriasis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2014-05-20